This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to recent reporting , pet industry spending is expected to reach $96 billion by 2020 with CBD as one of its fastest growing sections. Yet, public demand for Hemp-CBD pet products may be pushing the market ahead regardless of legal requirements. While there are many Hemp-CBD pet products on the U.S. FEDERAL POLICIES.
The letter accused Curaleaf of “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.”
5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Available at: www.fda.gov/media/131878/download.
The letters also explain that because CBD is an active ingredient in the epilepsy drug, Epidiolex , products containing CBD are therefore outside the definition of a dietary supplement and cannot be added to food products.
From professional athletes to Hollywood celebrities to pet owners with high-strung Yorkie’s , everyone seems to be touting the apparently miraculous benefits of cannabidiol (CBD), a naturally occurring chemical compound derived from the cannabis plant. Authored By: Stacey Worthy.
In fact, if I think about it, I first saw hemp-derived CBD (Hemp CBD) “in the wild” at my local pet store here in Seattle. That changed when I started looking into Hemp CBD pet products in preparing for a CLE put on by the Seminar Group. Many pets, like humans, have an endocannabinoid system. .
As the public becomes more aware, businesses have been aggressively pursuing market share by peddling their own versions of hemp CBD products for humans and pets across all types of marketing platforms. The FDA also asserted that CBD was considered a drug because FDA had approved Epidiolex, a marijuana derived CBD drug for epilepsy.
From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. CBD is safe for pets, with products specifically formulated for cats, dogs, and horses. Endocannabinoids and epilepsy - Science Direct. Privacy Policy and all Terms & Conditions printed on this site. Cannabis sativa L.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content